0000950142-14-000380.txt : 20140213 0000950142-14-000380.hdr.sgml : 20140213 20140213161539 ACCESSION NUMBER: 0000950142-14-000380 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20131231 FILED AS OF DATE: 20140213 DATE AS OF CHANGE: 20140213 EFFECTIVENESS DATE: 20140213 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Aisling Capital LLC CENTRAL INDEX KEY: 0001571076 IRS NUMBER: 010849048 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-15878 FILM NUMBER: 14606289 BUSINESS ADDRESS: STREET 1: 888 SEVENTH AVENUE, 30TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10106 BUSINESS PHONE: 212-651-6372 MAIL ADDRESS: STREET 1: 888 SEVENTH AVENUE, 30TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10106 13F-HR 1 primary_doc.xml 13F-HR LIVE false false false 0001571076 XXXXXXXX 12-31-2013 12-31-2013 false Aisling Capital LLC

888 Seventh Avenue, 30th Floor New York NY 10106

13F HOLDINGS REPORT 028-15878 N Lloyd Appel 212-651-6372 /s/ Lloyd Appel New York NY 02-13-2014 0 6 163600 INFORMATION TABLE 2 infotable.xml Durata Therapeutics, Inc. Common Stock 26658A107 40000 3130824 SH SOLE 3130824 0 0 Quintiles Transnational Corp. Common Stock 74876Y101 84500 1823575 SH SOLE 1823575 0 0 Intercept Pharmaceuticals Common Stock 45845P108 9400 137519 SH SOLE 137519 0 0 Chimerix, Inc. Common Stock 16934W106 18500 1222943 SH SOLE 1222943 0 0 MEI Pharma, Inc. Common Stock 57232I303 6200 770000 SH SOLE 770000 0 0 Sorrento Therapeutics, Inc Common Stock 83587F202 5000 620700 SH SOLE 620700 0 0